Part E: Debates on Immunotherapy for Recurrent Pregnancy Failure
Pp. 724-734 (11)
This chapter briefly summarizes the reasons which I put forwards at the time to discard tmost of the immunotherapy approach for recurrent pregnancy failure, and the recent developments which make me partly revise my opinion, since a safe and effective treatment might have been proposed.
Abortion, immunotherapy, history, concerns, cochrane, efficiency, inocuity, TNF, regulators.
Director of Research Emeritus, U976 INSERM /UMR 976 CNRS Saint Louis Hospital 75010, Paris France.